Drug Trials News for September 2014

Breakthrough Melanoma Treatment, Keytruda, Developed Using Antibody Humanization Expertise at UK’s MRC Technology Breakthrough Melanoma Treatment, Keytruda, Developed Using Antibody Humanization Expertise at UK’s MRC Technology

New immunotherapy launched in the US for treatment of adults with advanced melanoma
05 September, 2014